Sign inJoin waitlistJoin the waitlist

ML

Moshe Levy

Physician · Texas Oncology

Credentials: · · · ·

History

Texas Oncology
Present

Medical Oncology
2004–2006
UPMC
1999–2002
University of Wisconsin School of Medicine and Public Health
1995–1999

Research

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma
New England Journal of Medicine · 2019 · 537 citations
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label,…
The Lancet · 2020 · 271 citations
Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review
Review · JAMA Oncology · 2018 · 184 citations

JS
Jatin Shah
8 papers
Paul Richardson
8 papers
Sundar Jagannath
7 papers
NB
Nizar Jacques Bahlis
6 papers
DS
Don Stevens
5 papers
Larry Anderson
5 papers
MG
Mitul Gandhi
4 papers
Ajai Chari
3 papers
Ashraf Badros
3 papers
BS
Bruce Smith
3 papers
EF
Ephraim Fuchs
3 papers
JL
Jeffrey Lancet
3 papers

Clinical trials

Asciminib Roll-over Study
Site PI · Recruiting · Phase 4
Novartis Pharmaceuticals
2022–2030
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
Site PI · Unknown · Phase 1, Phase 2
Ascentage Pharma Group Inc.
2020–2025